Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Buy dildos and vibrators.
Popular Articles

When Husbands Work In US, Mexican Wives' Mental Health Dives
Selected highlights from a new study on immigration, health and gender roles:
buy viagra
Head-to-head Trial Demonstrates Viramune®`s Similar Efficacy And Superior Effect On Lipid Profile Compared To Atazanavir/ritonavir
Results from the ARTEN trial presented at the 5th International AIDS Society (IAS) conference in Cape Town, South Africa demonstrated non-inferiority regarding efficacy between Viramune® (nevirapine) and ritonavir boosted atazanavir (atazanavir/r) both combined with tenofovir and emtricitabine (Truvada ®). This head-to-head study also showed Viramune®Â´s more favourable effect on the lipid profile and now clearly confirms the combination"s place as an important first line therapy for patients with HIV.
News of the day
Strong Immune Response To New SiRNA Drugs In Development May Cause Toxic Side Effects
Small synthetic fragments of genetic material called small interfering RNA (siRNA) can block production of abnormal proteins; however, these exciting new drug candidates can also induce a strong immune response, causing toxic side effects. Understanding how siRNA stimulates this undesirable immune activity, how to test for it, and how to design siRNA drugs to avoid it are critical topics explored in a timely review article published online ahead of print in Oligonucleotides, a peer-reviewed journal published by Mary Ann Liebert, Inc.
Cardiovascular

Uganda's Health Ministry Orders Investigations Into Deaths Of Patients Living With HIV

Uganda"s Health Ministry announced Monday it has ordered investigations into whether the deaths of 17 patients living with HIV in Northern Uganda were caused by their inability to get antiretroviral (ARV) drugs, the AP/mlive.com reports. According to Zainab Akol, manager of the ministry"s HIV/AIDS control program, the ministry is exploring "whether apart from the lack of ARVs, another disease like malaria or any epidemic could have contributed to the deaths," according to the news service. The article examines assertions that Uganda is exepriencing a shortage of antiretrovirals. Akol "attributed the shortage of antiretroviral drugs to a sharp increase this year in the number of AIDS patients," after a countrywide testing campaign identified 100,000 addition HIV-positive people. "The number of HIV/AIDS patients increased yet money provided by donors to buy the drugs did not increase," said Akol. The article includes comments by Stephen Watiti of Uganda"s National Forum of People Living with HIV-AIDS Network, who "said his group has also received reports about the 17 HIV patients dying in northern Uganda and is investigating whether patients in other areas of the country are affected." Watiti commented that some government health centers has stopped providing antiretrovirals to HIV-positive patients and that treatment interruption "could expose Uganda to "an explosion of a new HIV epidemic that is predominantly drug resistant"" (Olukya, 7/27). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009